ESC Premium Access

Circulating fibroblast growth factor 21 is associated with diastolic dysfunction in patients with preserved ejection fraction

Topic: Diastolic dysfunction

Congress Presentation

About the speaker

Doctor Ruey-Hsing Chou

Taipei Veterans General Hospital, Taipei (Taiwan)
0 follower

9 more presentations in this session

Prognostic Utility of GDF-15 in Chronic Heart Failure: Insights From the HF-ACTION Study

Speaker: Doctor A. Sharma (Durham, US)

Thumbnail

Circulating miR-122-5p and miR-124a-3p predict outcome in out-of-hospital cardiac arrest patients.

Speaker: Mr A. Salgado Somoza (Luxembourg, LU)

Thumbnail

Biomarkers in heart failure and adiposity results from the Gutenberg health study and validation in FINRISK

Speaker: Doctor C. Sinning (Hamburg, DE)

Thumbnail

A multi-time-point based multimarker risk stratification strategy in acute heart failure - results from the RELAX-AHF trial

Speaker: Doctor B. Demissei (Groningen, NL)

Thumbnail

Prediction of recurrent hospitalizations in heart failure using a multi-biomarker panel

Speaker: Doctor A. Bayes Genis (Badalona, ES)

Thumbnail

Access the full session

Biomarkers made easy

Speakers: Doctor R. Chou, Doctor A. Sharma, Mr A. Salgado Somoza, Doctor C. Sinning, Doctor B. Demissei...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb